Exploiting epigenetic dysregulation for sarcoma treatment

Active Project Grant Awarded Last action

Award ID
HT9425261E461
Recipient
Awarding agency
Obligated
$560,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 0% complete
Place of performance
Madison, WI 53715, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded the University of Wisconsin – Madison $560,000 on November 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support research into exploiting epigenetic dysregulation for sarcoma treatment. The project will run through October 31, 2029, with work performed in Madison, Wisconsin. This is a Project Grant assistance type supporting basic and applied biomedical research aimed at transforming health care for Service Members and the American public through innovative medical solutions.

Quick answers

Who received award HT9425261E461?

HT9425261E461 was awarded to University Of Wisconsin System by Defense Health Agency (Department of Defense) on November 1, 2026.

How much is award HT9425261E461 worth?

$560,000 has been obligated on HT9425261E461.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login